1. Home
  2. MLP vs ALT Comparison

MLP vs ALT Comparison

Compare MLP & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLP
  • ALT
  • Stock Information
  • Founded
  • MLP 1909
  • ALT 1997
  • Country
  • MLP United States
  • ALT United States
  • Employees
  • MLP N/A
  • ALT N/A
  • Industry
  • MLP Real Estate
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLP Finance
  • ALT Health Care
  • Exchange
  • MLP Nasdaq
  • ALT Nasdaq
  • Market Cap
  • MLP 343.9M
  • ALT 292.0M
  • IPO Year
  • MLP 1972
  • ALT N/A
  • Fundamental
  • Price
  • MLP $17.50
  • ALT $3.83
  • Analyst Decision
  • MLP
  • ALT Strong Buy
  • Analyst Count
  • MLP 0
  • ALT 6
  • Target Price
  • MLP N/A
  • ALT $17.40
  • AVG Volume (30 Days)
  • MLP 15.7K
  • ALT 3.0M
  • Earning Date
  • MLP 08-14-2025
  • ALT 08-12-2025
  • Dividend Yield
  • MLP N/A
  • ALT N/A
  • EPS Growth
  • MLP N/A
  • ALT N/A
  • EPS
  • MLP N/A
  • ALT N/A
  • Revenue
  • MLP $16,843,000.00
  • ALT $20,000.00
  • Revenue This Year
  • MLP N/A
  • ALT N/A
  • Revenue Next Year
  • MLP N/A
  • ALT $761,880.20
  • P/E Ratio
  • MLP N/A
  • ALT N/A
  • Revenue Growth
  • MLP 74.59
  • ALT N/A
  • 52 Week Low
  • MLP $14.05
  • ALT $2.90
  • 52 Week High
  • MLP $26.46
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • MLP 53.69
  • ALT 51.79
  • Support Level
  • MLP $16.41
  • ALT $3.35
  • Resistance Level
  • MLP $17.49
  • ALT $3.66
  • Average True Range (ATR)
  • MLP 0.56
  • ALT 0.19
  • MACD
  • MLP 0.10
  • ALT 0.07
  • Stochastic Oscillator
  • MLP 81.63
  • ALT 86.18

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: